Piperlongumine [29] inhibits cancer growth by inducing the accumulation of intracellular ROS, decreasing glutathione, damaging chromosomal DNA, and modulating key regulatory proteins, including PI3K, AKT, mTOR, NF-κB, STATs, and cyclin D1. Here, CCND1 is linked to cancer.